Dario Blood Glucose Monitoring System
Recall Z-0260-2020, part of FDA recall event 83761. See LabStyle Innovations's company page.
LABSTYLE INNOVATIONS started this Class II device recall on Aug 29, 2019 (voluntary: firm initiated); FDA lists it as terminated, terminated May 5, 2020.
- Classification: Class II
- Started: Aug 29, 2019
- Status: Terminated
The Dario-Blood Glucose Tracker Android App versions 4.3.0-4.3.2 may experience duplicate logging of a blood glucose level reading.
- Product
- Dario Blood Glucose Monitoring System, Model No. 1015-05, running Android software versions 4.3.0-4.3.2
- Quantity
- 126,271 (83,141 US; 43,130 OUS)
- Lots and codes
- Android App Software versions 4.3.0-4.3.2
- Distribution
- Nationwide domestic distribution. Foreign distribution to Australia, Canada, UK, and Italy.
- Recalling firm
- LABSTYLE INNOVATIONS, Ramat Gan, Israel
- How the firm notified
- Other
- FDA classified
- Oct 31, 2019
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports